Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2017

Conditions
Lung Cancer
Interventions
GENETIC

DNA analysis

GENETIC

DNA methylation analysis

GENETIC

RNA analysis

GENETIC

gene expression analysis

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

OTHER

medical chart review

Trial Locations (11)

19713

CCOP - Christiana Care Health Services, Newark

19958

Tunnell Cancer Center at Beebe Medical Center, Lewes

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

21921

Union Hospital of Cecil County, Elkton

27710

Duke Cancer Institute, Durham

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

90048

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

14263-0001

Roswell Park Cancer Institute, Buffalo

02903

Rhode Island Hospital Comprehensive Cancer Center, Providence

02906

Miriam Hospital, Providence

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT01414595 - Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter